Unity Biotechnology, Inc.
UBX
$0.977
-$0.0067-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -25.50% | -30.09% | -86.17% | -83.61% | -35.40% |
| Gross Profit | 25.50% | 30.09% | 86.17% | 83.61% | 35.40% |
| SG&A Expenses | 6.21% | 1.07% | -12.24% | -35.05% | -19.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.32% | 2.95% | -26.47% | -41.10% | -28.03% |
| Operating Income | 9.32% | -2.95% | 26.47% | 41.10% | 28.03% |
| Income Before Tax | -26.11% | -94.47% | 56.16% | 65.84% | -9.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.11% | -94.47% | 56.16% | 65.84% | -9.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.11% | -94.47% | 56.16% | 65.84% | -9.68% |
| EBIT | 9.32% | -2.95% | 26.47% | 41.10% | 28.03% |
| EBITDA | 8.94% | -3.46% | 26.35% | 41.41% | 27.93% |
| EPS Basic | -25.49% | -81.61% | 62.02% | 70.70% | 6.48% |
| Normalized Basic EPS | -25.46% | -43.16% | 38.83% | 70.70% | 6.46% |
| EPS Diluted | -25.49% | -81.61% | 62.02% | 70.70% | 6.48% |
| Normalized Diluted EPS | -25.46% | -43.16% | 38.83% | 70.70% | 6.46% |
| Average Basic Shares Outstanding | 0.51% | 7.08% | 15.42% | 16.56% | 17.27% |
| Average Diluted Shares Outstanding | 0.51% | 7.08% | 15.42% | 16.56% | 17.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |